The cost‐effectiveness and budgetary impact of a dolutegravir‐based regimen as first‐line treatment of HIV infection in India

INTRODUCTION: Dolutegravir (DTG)‐based antiretroviral therapy (ART) is recommended for first‐line HIV treatment in the US and Europe. Efavirenz (EFV)‐based regimens remain the standard of care (SOC) in India. We examined the clinical and economic impact of DTG‐based first‐line ART in the setting of...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Int AIDS Soc
Hlavní autoři: Zheng, Amy, Kumarasamy, Nagalingeswaran, Huang, Mingshu, Paltiel, A David, Mayer, Kenneth H, Rewari, Bharat B, Walensky, Rochelle P, Freedberg, Kenneth A
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2018
Témata:
Research Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5878415/
https://ncbi.nlm.nih.gov/pubmed/29603882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jia2.25085
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky